Literature DB >> 12782575

Mouse embryos cloned from brain tumors.

Leyi Li1, Michele C Connelly, Cynthia Wetmore, Tom Curran, James I Morgan.   

Abstract

Cancer cells escape from growth control by accumulating genetic and epigenetic alterations. In rare instances, epigenetic changes alone are oncogenic. Furthermore, agents that modify DNA methylation or chromatin structure can restore a normal phenotype to cells harboring oncogenic mutations. However, it is unclear to what extent epigenetic reprogramming can reverse oncogenesis. Using somatic nuclear transfer, we show that medulloblastomas arising in Ptc1+/- mice can direct preimplantation development. Additionally, blastocysts derived from medulloblastoma nuclei form postimplantation embryos with typical cell layers. Thus, tumor cells can be epigenetically reprogrammed into normal cell types. This approach could lead to a general strategy for assessing genetic and epigenetic contributions to tumorigenesis.

Entities:  

Mesh:

Year:  2003        PMID: 12782575

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Self-organization vs Watchmaker: stochastic gene expression and cell differentiation.

Authors:  Alexei Kurakin
Journal:  Dev Genes Evol       Date:  2004-11-30       Impact factor: 0.900

2.  Exposure of mouse cumulus cell nuclei to porcine ooplasmic extract eliminates TATA box protein binding to chromatin, but has no effect on DNA methylation.

Authors:  Guo Qing Tong; Boon Chin Heng; Soon Chye Ng
Journal:  J Assist Reprod Genet       Date:  2006-12-07       Impact factor: 3.412

Review 3.  Epigenetic reprogramming and induced pluripotency.

Authors:  Konrad Hochedlinger; Kathrin Plath
Journal:  Development       Date:  2009-02       Impact factor: 6.868

Review 4.  Theories of carcinogenesis: an emerging perspective.

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

5.  H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.

Authors:  Jia-Yi Yao; Lei Zhang; Xin Zhang; Zhi-Ying He; Yue Ma; Li-Jian Hui; Xin Wang; Yi-Ping Hu
Journal:  J Biol Chem       Date:  2010-04-10       Impact factor: 5.157

6.  N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma.

Authors:  Jessica D Kessler; Hiroshi Hasegawa; Sonja N Brun; Brian A Emmenegger; Zeng-Jie Yang; John W Dutton; Fan Wang; Robert J Wechsler-Reya
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

7.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

8.  Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.

Authors:  Gang Chang; Yi-Liang Miao; Yu Zhang; Sheng Liu; Zhaohui Kou; Junjun Ding; Da-Yuan Chen; Qing-Yuan Sun; Shaorong Gao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

9.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

10.  Cytotoxicity of unsaturated fatty acids in fresh human tumor explants: concentration thresholds and implications for clinical efficacy.

Authors:  David E Scheim
Journal:  Lipids Health Dis       Date:  2009-12-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.